| |
| |
|
| Insider
Information: |
Duvall Martin J |
| Relationship: |
Chief Executive Office... |
| City: |
Bloomington |
| State: |
MN |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
3 |
|
| Direct
Shares |
113,144 |
|
|
Indirect Shares
|
585 |
|
|
| Direct
Value |
$17,142 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
113,729 |
|
|
| Total
Value |
$17,142 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
MGI Pharma Inc |
MOGN |
Sr VP Commercial Opera... |
2005-12-16 |
6,500 |
2005-12-16 |
585 |
Premium* |
|
|
Ariad Pharmaceuticals Inc |
ARIA |
EVP, CCO |
2016-03-19 |
93,039 |
2013-03-20 |
0 |
Premium* |
|
|
Forte Biosciences Inc |
FBRX |
Chief Executive Office... |
2019-05-28 |
13,605 |
2017-04-19 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| FBRX |
Forte Biosciences Inc |
Chief Executive Officer |
• • – |
2019-05-28 |
4 |
B |
$4.34 |
$21,679 |
D/D |
5,000 |
13,605 |
2.81 |
- |
|
| FBRX |
Forte Biosciences Inc |
Chief Executive Officer |
• • – |
2017-12-08 |
4 |
A |
$8.50 |
$21,250 |
D/D |
2,500 |
6,071 |
0 |
- |
|
| FBRX |
Forte Biosciences Inc |
Chief Executive Officer |
• • – |
2017-04-19 |
4 |
A |
$10.00 |
$35,710 |
D/D |
3,571 |
3,571 |
0 |
- |
|
| ARIA |
Ariad Pharmaceuticals Inc |
EVP, CCO |
• – – |
2016-03-19 |
4 |
AS |
$6.47 |
$25,867 |
D/D |
(4,000) |
93,039 |
0 |
- |
|
| ARIA |
Ariad Pharmaceuticals Inc |
EVP, CCO |
• – – |
2016-03-19 |
4 |
OE |
$0.00 |
$0 |
D/D |
8,000 |
97,039 |
0 |
- |
|
| ARIA |
Ariad Pharmaceuticals Inc |
EVP, CCO |
• • – |
2016-03-03 |
4 |
AS |
$6.12 |
$58,863 |
D/D |
(9,625) |
89,039 |
0 |
- |
|
| ARIA |
Ariad Pharmaceuticals Inc |
EVP, CCO |
• • – |
2016-03-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
19,250 |
98,664 |
0 |
- |
|
| ARIA |
Ariad Pharmaceuticals Inc |
EVP, CCO |
• • – |
2016-02-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
29,333 |
94,081 |
0 |
- |
|
| ARIA |
Ariad Pharmaceuticals Inc |
EVP, CCO |
• • – |
2016-02-01 |
4 |
AS |
$4.81 |
$70,578 |
D/D |
(14,667) |
79,414 |
0 |
- |
|
| ARIA |
Ariad Pharmaceuticals Inc |
EVP, CCO |
• • – |
2015-09-28 |
4 |
AS |
$6.46 |
$32,317 |
D/D |
(5,000) |
64,748 |
0 |
- |
|
| ARIA |
Ariad Pharmaceuticals Inc |
EVP, CCO |
• • – |
2015-09-24 |
4 |
OE |
$0.00 |
$0 |
D/D |
10,000 |
69,748 |
0 |
- |
|
| ARIA |
Ariad Pharmaceuticals Inc |
EVP, CCO |
• • – |
2015-07-16 |
4 |
AS |
$8.54 |
$11,956 |
D/D |
(1,400) |
59,748 |
0 |
- |
|
| ARIA |
Ariad Pharmaceuticals Inc |
EVP, CCO |
• • – |
2015-07-15 |
4 |
OE |
$0.00 |
$0 |
D/D |
2,800 |
61,148 |
0 |
- |
|
| ARIA |
Ariad Pharmaceuticals Inc |
EVP, CCO |
• • – |
2015-03-23 |
4 |
AS |
$8.57 |
$7,145 |
D/D |
(834) |
54,950 |
0 |
- |
|
| ARIA |
Ariad Pharmaceuticals Inc |
EVP, CCO |
• • – |
2015-03-20 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,667 |
55,784 |
0 |
- |
|
| ARIA |
Ariad Pharmaceuticals Inc |
EVP, CCO |
• • – |
2015-03-20 |
4 |
AS |
$8.85 |
$35,381 |
D/D |
(4,000) |
54,117 |
0 |
- |
|
| ARIA |
Ariad Pharmaceuticals Inc |
EVP, CCO |
• • – |
2015-03-19 |
4 |
OE |
$0.00 |
$0 |
D/D |
8,000 |
58,117 |
0 |
- |
|
| ARIA |
Ariad Pharmaceuticals Inc |
EVP, CCO |
• • – |
2015-02-02 |
4 |
AS |
$6.33 |
$92,823 |
D/D |
(14,667) |
50,117 |
0 |
- |
|
| ARIA |
Ariad Pharmaceuticals Inc |
EVP, CCO |
• • – |
2015-02-02 |
4 |
OE |
$0.00 |
$0 |
D/D |
29,334 |
64,784 |
0 |
- |
|
| ARIA |
Ariad Pharmaceuticals Inc |
EVP, CCO |
• • – |
2014-07-15 |
4 |
D |
$5.57 |
$5,085 |
D/D |
(913) |
35,450 |
0 |
- |
|
| ARIA |
Ariad Pharmaceuticals Inc |
EVP, CCO |
• • – |
2014-07-15 |
4 |
OE |
$0.00 |
$0 |
D/D |
2,800 |
36,363 |
0 |
- |
|
| ARIA |
Ariad Pharmaceuticals Inc |
EVP, CCO |
• • – |
2014-03-20 |
4 |
D |
$8.13 |
$4,301 |
D/D |
(529) |
30,340 |
0 |
- |
|
| ARIA |
Ariad Pharmaceuticals Inc |
EVP, CCO |
• • – |
2014-03-20 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,666 |
30,869 |
0 |
- |
|
| ARIA |
Ariad Pharmaceuticals Inc |
EVP, CCO |
• • – |
2014-03-19 |
4 |
D |
$8.19 |
$21,441 |
D/D |
(2,618) |
29,203 |
0 |
- |
|
| ARIA |
Ariad Pharmaceuticals Inc |
EVP, CCO |
• • – |
2014-03-19 |
4 |
OE |
$0.00 |
$0 |
D/D |
8,000 |
31,821 |
0 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
